This CE course for Nurse Practitioners (APRN/NP) provides insights into the latest pharmacotherapy advancements, focusing on newly approved drugs in 2024. Participants will explore these emerging therapies' indications, mechanisms, dosing, and administration methods. The course emphasizes safe prescribing practices, adverse reaction management, and patient-specific treatment strategies, equipping NPs to integrate cutting-edge pharmacotherapies into clinical practice to address unmet medical needs and improve outcomes in specialized disease states